(The Hill) – Lupin Pharmaceuticals Inc. recalls four lots of its blood pressure medication, Quinapril Tablets, because of an impurity known as Nitrosamines being found in recent testing of the product, according to the Food and Drug Administration (FDA).
The FDA stated that no illness related to the medication has yet been reported and that the marketing of the Quinapril Tablets ended in September. Quinapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and lower blood pressure.
The tablets were contaminated by a substance known as Nitrosamines, which the FDA reports is commonly found in food and water.
Hotter Today but Cooldown for Wednesday
Employees Still Waiting to Hear From Branson Tri-Lakes Newspaper Management
Informational Meeting About Fire and Police Tax Thursday
Tick Season Is in Full Force
What is the Potential Heat Index Readings for This Week? Update